Latest News
Taiwan’s "AI Medical Team" Debuts: 35 Hidden Champions from Three National Science Parks
2026-03-31

At the 2025 Taiwan Healthcare+ Expo, the National Science and Technology Council (NSTC) unified the Hsinchu, Central, and Southern Taiwan Science Parks to present 35 elite biomedical firms. The "Science Park Pavilion" focuses on the convergence of ICT, semiconductors, and precision health.

Hsinchu Science Park (HSP): Leveraging ICT for MedTech Innovation

With 154 resident firms and revenues exceeding NT$20.9 billion, HSP showcased 13 leaders in diagnostics and tele-health:

  • Medimaging Integrated Solution (晉弘科技): Handheld OCT for remote retinal screening.
  • Han Biomedical (瀚生醫電): Microwell array chips for ultra-early Alzheimer’s and Parkinson’s detection from blood.
  • Apex Bio (五鼎): Integrated blood glucose/ketone monitoring for diabetes management.
  • Energy Resources International (能資國際): Portable X-ray systems featuring Carbon Nanotube (CNT) technology for field diagnostics.
  • Chinan Biotech (錫安生技): Targeted proton therapy systems for precision oncology.
  • AeproMED Innovation (利優生醫): Intelligent nebulizer platforms for optimized aerosol drug delivery.

Central Taiwan Science Park (CTSP): Cross-Disciplinary Precision Health

Focusing on the "Industry-Academia-Medicine" nexus:

  • Darwin Precisions (達運精密): Biomimetic Organ-on-a-Chip platforms as alternatives to animal testing in drug toxicity studies.
  • Taiwan Main Orthopaedics Biotechnology (台灣骨王): AR smart glasses for 3D surgical planning in spinal and trauma surgery.
  • Kim Forest Biotechnology (瑞基海洋): Automated NGS (Next-Generation Sequencing) library preparation systems (SATLite).

Southern Taiwan Science Park (STTP): The Three Pillars of Regeneration and Care

With 83 firms and NT$13.5 billion in revenue, STTP serves as Taiwan’s largest smart-biomedical cluster:

  • BIONET Therapeutics (訊聯細胞智藥): Cell therapy and Exosome R&D for neurology and wound healing.
  • ACRO Biomedical (亞果生技): World-first Supercritical CO2 decellularization technology for regenerative scaffolds.
  • Biomdcare (柏瑞醫): Partnering with Illumina to launch "AI × NGS" integrated genomic-clinical platforms for oncology and osteoporosis risk prediction.

Resource: 台灣AI醫療隊來了!3大科學園區聯手 35家隱形冠軍殺進世界盃

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.
© 2026 Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
Address:9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number:(02)2655-8168 Fax:(02)2655-7978